Moderna's Strategic Shift Towards Oncology: Implications Ahead
Moderna's pivot to oncology reflects broader trends in biotech, with potential risks and opportunities for investors and stakeholders.
Browse the full archive, newest first.
Moderna's pivot to oncology reflects broader trends in biotech, with potential risks and opportunities for investors and stakeholders.
Robinhood's public offering of a $658 million private markets fund may reshape retail investment dynamics, but risks and implications warrant scrutiny.
Servier's acquisition of Day One Biopharmaceuticals for $2.5 billion could reshape its position in the pediatric oncology market, but risks remain.
Executive context: Exploring the rise of doppelgangers in culture, from AI twins to unsettling novels.
Justice Thomas' virtual attendance at a legal conference reignites scrutiny over court security and the unresolved Dobbs leak, highlighting systemic vulnerabilities.
Strategic implications in focus: China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded.
The latest findings reveal that the rate of global warming has accelerated significantly since 2015, posing a serious risk to the Paris Agreement's 1.5C target by 2030.
Executive context: With voting now closed, the months-long campaign for Oscar glory is over – but industry insiders are still dissecting every award-season clue in a tight best picture race.
Executive context: The Sonic Youth musician will answer your queries ahead of the release of her third solo album.
Strategic implications in focus: Researchers identify sharp rise to about 0.35C every decade, after excluding natural fluctuations such as El Niño.